Nurse Arcade
Pharmacology
Learn the class. Connect the indication. Anticipate the risk.
Start here
How to use the class tables
Representative ADN-level medications; not a formulary or prescribing guide.
1 – Class
Learn the shared mechanism and predictable class effects before memorizing individual names.
2 – Indication
Connect every medication to why this patient is receiving it and the outcome you expect.
3 – Safety
Check allergies, baseline assessment, labs, route and form, interactions, organ function, and ordered parameters.
4 – Reassess
Evaluate therapeutic response and adverse effects at the medication-appropriate time.
5 – Teach
Explain purpose, schedule, administration, common effects, red flags, and when to seek help.
Drug class review
Medication foundations
Rights, reconciliation, kinetics, safety
Medication administration begins with indication, allergies and reactions, current medications and substances, route and form, renal and hepatic function, baseline assessment, and a plan to evaluate effect.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Seven rights | Every medication administration | Preventable harm when any right is wrong | Interruptions, look-alike names, duplicate products | Stop and clarify every mismatch or incomplete order |
| Medication reconciliation | Transitions and every encounter | Omission, duplication, interaction, withdrawal | Prescription, OTC, alcohol, nicotine, supplements, food | Compare the best possible list with current orders |
| ADME and half-life | Predict onset, duration, accumulation, clearance | Toxicity with impaired kidney or liver function | Inducers, inhibitors, and competing clearance | Verify organ function, age, weight, route, timing, and levels |
| High-alert safeguards | Insulin, anticoagulants, opioids, electrolytes, chemotherapy, sedation | Severe harm from small errors | Multiple high-risk drugs compound harm | Use required independent checks and smart-pump libraries |
Drug class review
Analgesics and anti-inflammatory drugs
Pain, fever, inflammation
Nonopioids reduce pain and fever; NSAIDs also reduce inflammation but can injure the GI tract and kidneys. Opioids can depress respiration.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Acetaminophen | Pain, fever | Nausea; hepatotoxicity in overdose | Alcohol; duplicate combination products | Verify total daily dose and liver risk |
| Ibuprofen, naproxen, ketorolac | Pain, inflammation | GI bleeding, renal injury, fluid retention | Anticoagulants, steroids, ACEI or ARB plus diuretics | Verify bleeding, renal, ulcer, and volume risk |
| Aspirin | Pain, fever; antiplatelet therapy | GI bleeding, tinnitus, bronchospasm | Anticoagulants, NSAIDs, alcohol | Verify indication and bleeding risk |
| Morphine, hydromorphone, oxycodone, fentanyl | Moderate to severe pain | Sedation, constipation, hypotension, respiratory depression | Alcohol, benzodiazepines, other sedatives | Hold or escalate unsafe sedation or respirations per order and policy |
| Naloxone | Opioid reversal | Acute withdrawal; recurrent sedation | Opioid duration may exceed naloxone | Reassess breathing and repeat per protocol |
Drug class review
Antibiotics
Bacterial infections
Antibiotics target bacterial structures or processes. Obtain cultures when ordered, assess allergy history carefully, give on schedule, and monitor clinical response and organ function.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Penicillin, amoxicillin, piperacillin-tazobactam | Streptococcal, respiratory, skin, broad inpatient infections | Rash, diarrhea, anaphylaxis | Methotrexate; warfarin effects may change | Hold and escalate suspected anaphylaxis or severe rash |
| Cephalexin, ceftriaxone, cefepime | Skin, urinary, respiratory, serious gram-negative infections | GI effects, allergy, C. difficile, neurotoxicity risk | Warfarin; product-specific compatibility | Verify allergy and renal dosing |
| Azithromycin | Respiratory and STI infections | GI upset, QT prolongation | Other QT-prolonging drugs | Verify QT and electrolyte risk |
| Doxycycline | Tick-borne, acne, atypical infections | Photosensitivity, esophagitis | Antacids and iron reduce absorption | Separate interacting products; check pregnancy and age considerations |
| Vancomycin | Serious gram-positive and MRSA infections | Infusion reaction, nephrotoxicity, ototoxicity | Other nephrotoxins | Verify AUC or level plan and renal function |
| Gentamicin, tobramycin | Serious gram-negative infections | Nephrotoxicity, ototoxicity | Loop diuretics and other nephrotoxins | Verify levels and renal function |
| Ciprofloxacin, levofloxacin | Selected urinary and respiratory infections | Tendon injury, neuropathy, CNS effects, QT change | Cations, steroids, QT drugs | Report tendon or neurologic symptoms |
| Metronidazole | Anaerobic and protozoal infections | GI upset, metallic taste, neuropathy | Alcohol, warfarin | Avoid alcohol; monitor interaction |
Drug class review
Anticoagulants, antiplatelets and thrombolytics
Prevent or treat thrombosis
These drugs reduce clot formation or platelet aggregation. Balance thrombosis prevention with bleeding risk and use the correct monitoring and reversal pathway.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Heparin | VTE and ACS treatment or prevention | Bleeding, HIT | Antiplatelets, NSAIDs | Verify aPTT or anti-Xa protocol and platelets; stop and escalate suspected HIT |
| Enoxaparin | VTE and ACS | Bleeding, thrombocytopenia | NSAIDs, antiplatelets | Verify renal function, weight, platelets, and neuraxial timing |
| Warfarin | AF, VTE, selected valves | Bleeding, skin necrosis, fetal harm | Many drugs; vitamin K intake changes | Verify INR and indication; hold only per order or protocol |
| Apixaban, rivaroxaban, dabigatran | AF and VTE | Bleeding | Strong CYP or P-gp modifiers; NSAIDs | Verify renal and hepatic function and last dose |
| Aspirin, clopidogrel | ACS, stroke, stent prevention | Bleeding, bruising | NSAIDs, anticoagulants | Verify bleeding and procedure plan |
| Alteplase, tenecteplase | Selected ischemic stroke, MI, or PE | Major or intracranial bleeding | Anticoagulants and antiplatelets | Use strict checklist, timing, BP, labs, and contraindications |
Drug class review
Antihypertensives
Hypertension, heart failure, rate control
These classes lower blood pressure through RAAS blockade, vascular effects, reduced sympathetic tone, or slower heart rate. Trend BP, renal function, potassium, and symptoms.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Lisinopril, enalapril | HTN, HF, renal protection | Cough, hyperkalemia, hypotension, angioedema, renal change | Potassium, NSAIDs, lithium | Escalate angioedema; verify BP, potassium, creatinine, pregnancy |
| Losartan, valsartan | HTN, HF, renal protection | Hyperkalemia, hypotension, renal change | Potassium, NSAIDs, lithium | Verify BP, potassium, renal function, pregnancy |
| Amlodipine, nifedipine | HTN, angina | Edema, flushing, headache, hypotension | CYP3A4 modifiers | Verify BP and symptomatic hypotension |
| Diltiazem, verapamil | Rate control, angina, HTN | Bradycardia, heart block, hypotension, constipation | Beta blockers, digoxin | Verify HR, BP, rhythm, and HF status |
| Metoprolol, carvedilol, propranolol | HTN, angina, rate control, HF, migraine | Bradycardia, hypotension, fatigue, bronchospasm; masks hypoglycemia | Other rate-slowing drugs | Use ordered HR and BP parameters; assess wheeze and perfusion |
| Clonidine | HTN | Sedation, dry mouth, bradycardia; rebound HTN | CNS depressants | Do not stop abruptly; verify BP and HR |
| Prazosin, tamsulosin | HTN; BPH symptoms | Orthostatic hypotension, dizziness | PDE-5 inhibitors, other BP drugs | Fall precautions; verify BP and symptoms |
Drug class review
Diuretics
Edema, heart failure, hypertension
Diuretics change sodium and water handling. Monitor weight and volume trends, BP, electrolytes, kidney function, and hearing with high-dose loop therapy.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Furosemide, bumetanide | Edema, HF, pulmonary congestion | Hypokalemia, dehydration, hypotension, renal change, ototoxicity | Digoxin, lithium, NSAIDs | Verify BP, potassium, magnesium, renal function, volume status |
| Hydrochlorothiazide, chlorthalidone | HTN, mild edema | Hyponatremia, hypokalemia, hyperuricemia, glucose change | Lithium, NSAIDs | Verify electrolytes, renal function, BP |
| Spironolactone, eplerenone | HF, aldosteronism, ascites | Hyperkalemia, renal change; gynecomastia with spironolactone | ACEI, ARB, potassium | Verify potassium and renal function |
| Mannitol | Raised ICP or IOP; selected renal uses | Fluid shifts, pulmonary edema, electrolyte change | Other nephrotoxic or volume-altering drugs | Verify osmolality, renal and cardiac status, and filter |
Drug class review
Cardiac and emergency drugs
Angina, dysrhythmia, heart failure, arrest
These agents can rapidly change rate, rhythm, contractility, vascular tone, or perfusion. Continuous assessment and indication-specific protocols matter.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Nitroglycerin | Angina, ACS, pulmonary edema | Headache, hypotension, reflex tachycardia | PDE-5 inhibitors, other BP drugs | Verify BP and recent PDE-5 use |
| Digoxin | HF symptom support, AF rate control | Bradycardia, dysrhythmia, GI or visual changes | Amiodarone, verapamil; low potassium increases toxicity | Verify apical rate, potassium, renal function, and level when ordered |
| Amiodarone | Atrial and ventricular dysrhythmias | Bradycardia, QT change, lung, liver, thyroid toxicity | Warfarin, digoxin, QT drugs | Verify rhythm, QT, BP, and organ monitoring |
| Adenosine | Selected regular narrow-complex SVT | Flushing, chest pressure, transient asystole, bronchospasm | Caffeine and theophylline; dipyridamole | Continuous ECG; rapid push per protocol; resuscitation readiness |
| Atropine | Symptomatic bradycardia; secretions | Tachycardia, dry mouth, urinary retention | Other anticholinergics | Verify rhythm and indication |
| Epinephrine, norepinephrine, dopamine, dobutamine | Arrest, shock, anaphylaxis, low output – agent specific | Dysrhythmia, ischemia, hypertension, extravasation | MAOI and other sympathomimetics | Continuous hemodynamic monitoring; verify concentration and line |
Drug class review
Respiratory drugs
Asthma, COPD, allergy, airway edema
Bronchodilators open airways; inhaled steroids control inflammation but do not rescue acute bronchospasm. Technique and device teaching are essential.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Albuterol | Acute bronchospasm | Tremor, tachycardia, hypokalemia | Other stimulants; nonselective beta blockers | Reassess breath sounds, HR, and work of breathing |
| Ipratropium, tiotropium | COPD and asthma adjunct | Dry mouth, urinary retention, glaucoma concern | Other anticholinergics | Avoid eye exposure; verify urinary and glaucoma risk |
| Fluticasone, budesonide | Asthma and COPD control | Thrush, dysphonia; systemic effects at high dose | Strong CYP3A4 inhibitors | Not rescue; rinse mouth |
| Montelukast | Asthma and allergic-rhinitis control | Neuropsychiatric effects | Review the complete profile | Report behavior or mood changes |
| Theophylline | Selected asthma or COPD | Nausea, tremor, seizures, dysrhythmia | Many CYP drugs; caffeine; smoking changes levels | Verify level, interactions, HR |
| Acetylcysteine | Mucolytic; acetaminophen antidote | Bronchospasm, nausea, anaphylactoid reaction IV | Activated-charcoal timing | Verify indication, protocol, and airway response |
Drug class review
Diabetes drugs
Diabetes and hyperglycemia
Match drug action to meals, renal function, illness, and glucose trend. Hypoglycemia is the immediate safety priority; insulin is high-alert.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Insulin lispro or aspart | Meal and correction glucose control | Hypoglycemia, hypokalemia | Other glucose drugs; beta blockers mask symptoms | Verify glucose, meal availability, dose, and independent check |
| Regular insulin | Meal or correction; IV DKA and hyperkalemia protocols | Hypoglycemia, hypokalemia | Other glucose-lowering drugs | Verify route and concentration; IV only by protocol |
| NPH insulin | Intermediate basal coverage | Hypoglycemia | Other glucose drugs | Verify timing, appearance, and mixing rules |
| Glargine, detemir, degludec | Basal coverage | Hypoglycemia | Other glucose drugs | Do not mix glargine; verify dose and trend |
| Metformin | Type 2 diabetes | GI effects, B12 reduction; rare lactic acidosis | Contrast and renal impairment increase risk | Verify eGFR and contrast or sick-day policy |
| Glipizide, glyburide | Type 2 diabetes | Hypoglycemia, weight gain | Alcohol, other glucose drugs | Verify glucose and meal; consider renal and older-adult risk |
| Semaglutide, liraglutide | Type 2 diabetes, weight and cardiovascular benefit | GI effects, gallbladder and pancreatitis concerns | Slows gastric emptying | Verify escalation and severe abdominal symptoms |
| Empagliflozin, dapagliflozin | Type 2 diabetes, HF and renal benefit | Genital infection, volume loss, euglycemic DKA | Diuretics | Verify renal function, hydration, and perioperative sick-day plan |
Drug class review
Thyroid and corticosteroids
Thyroid disorders, inflammation, adrenal replacement
Thyroid replacement requires consistent administration. Systemic corticosteroids alter immunity, glucose, mood, bone, fluid, and adrenal function.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Levothyroxine | Hypothyroidism | Overreplacement: tachycardia, tremor, insomnia | Iron, calcium, antacids; warfarin | Give consistently; verify TSH plan and cardiac symptoms |
| Methimazole, propylthiouracil | Hyperthyroidism | Agranulocytosis, hepatotoxicity | Warfarin and digoxin needs may change | Urgently report fever or sore throat; monitor liver cues |
| Prednisone, methylprednisolone, dexamethasone | Inflammation, immune disease, cerebral or airway edema | Hyperglycemia, infection, mood, GI, bone, adrenal effects | NSAIDs, vaccines, glucose drugs | Verify infection and glucose; do not abruptly stop long therapy |
| Hydrocortisone | Adrenal replacement, shock adjunct | Systemic corticosteroid effects | Same class interactions | Stress dosing and taper per plan |
Drug class review
GI drugs
Acid disease, nausea, bowel disorders
GI drugs alter acid, motility, secretion, or emesis pathways. Identify obstruction, bleeding, severe abdominal pain, and electrolyte loss before treating symptoms.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Omeprazole, pantoprazole | GERD, ulcer, GI bleed protocols | Headache; long-term low magnesium or B12, fractures, infection | Clopidogrel interaction strongest with omeprazole | Verify indication and duration |
| Famotidine | GERD and ulcer | Headache, confusion in older or renal patients | May alter absorption of pH-dependent drugs | Verify renal dosing |
| Ondansetron | Nausea and vomiting | Headache, constipation, QT prolongation | Other QT and serotonergic drugs | Verify QT and electrolytes when at risk |
| Metoclopramide | Gastroparesis, nausea | EPS, tardive dyskinesia, sedation | Antipsychotics, serotonergic drugs | Hold and escalate abnormal movements |
| Loperamide | Diarrhea | Constipation, ileus; cardiac toxicity in overdose | QT drugs in misuse | Avoid with suspected invasive infection or ileus per plan |
| Lactulose | Constipation, hepatic encephalopathy | Diarrhea, electrolyte loss | Other laxatives | Titrate to ordered endpoint; verify hydration |
| Polyethylene glycol, senna, bisacodyl | Constipation | Cramping, diarrhea, electrolyte change | Other laxatives | Verify obstruction and bowel pattern |
Drug class review
Neurologic drugs
Seizures, neuropathic pain, Parkinson disease
Antiseizure therapy requires adherence and drug-specific monitoring. Many agents cause CNS depression and have major pregnancy or interaction considerations.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Levetiracetam | Seizures | Somnolence, dizziness, mood or behavior change | CNS depressants | Verify renal dosing; report suicidal or behavior change |
| Phenytoin | Seizures | Nystagmus, ataxia, gingival growth, rash, dysrhythmia IV | Many CYP interactions; tube feeds | Verify level, albumin, IV rate and line, rash |
| Valproate | Seizures, bipolar disorder, migraine | Hepatotoxicity, pancreatitis, thrombocytopenia, fetal harm | Many CNS and antiseizure drugs | Verify liver, platelets, pregnancy risk, level |
| Carbamazepine | Focal seizures, trigeminal neuralgia | Hyponatremia, marrow suppression, serious rash | Strong CYP inducer; grapefruit | Verify CBC, sodium, and screening plan |
| Gabapentin, pregabalin | Neuropathic pain, seizures | Sedation, dizziness, edema, respiratory risk with opioids | Opioids and CNS depressants | Verify renal dosing and sedation |
| Carbidopa-levodopa | Parkinson symptoms | Nausea, orthostasis, dyskinesia, hallucinations | Protein and iron can affect absorption; antipsychotics oppose | Give on time; verify mobility and mental status |
Drug class review
Psychiatric drugs
Depression, anxiety, bipolar disorder, psychosis
Monitor suicidality, serotonin toxicity, mania, extrapyramidal symptoms, metabolic effects, and cardiac conduction.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Sertraline, fluoxetine, escitalopram | Depression, anxiety | GI effects, sexual dysfunction, insomnia, hyponatremia, bleeding | MAOI, serotonergic drugs, NSAIDs | Monitor suicidality and serotonin syndrome; never combine with MAOI |
| Venlafaxine, duloxetine | Depression, anxiety; neuropathic pain | Nausea, BP increase, withdrawal | MAOI and serotonergic drugs | Verify BP and taper plan |
| Amitriptyline | Depression, neuropathic pain | Anticholinergic effects, orthostasis, overdose dysrhythmia | MAOI, QT and CNS depressants | Verify ECG or overdose risk and anticholinergic burden |
| Lorazepam, diazepam | Acute anxiety, seizures, withdrawal | Sedation, falls, respiratory depression, dependence | Opioids, alcohol, CNS depressants | Hold or escalate unsafe sedation or respiration; taper long use |
| Haloperidol | Psychosis, agitation | EPS, QT prolongation, NMS | QT drugs, CNS depressants | Monitor movement, temperature or rigidity, ECG risk |
| Quetiapine, risperidone, olanzapine | Psychosis, bipolar disorder | Sedation, orthostasis, metabolic effects, EPS | CNS depressants, BP drugs | Monitor weight, glucose, lipids, movement, BP |
| Lithium | Bipolar disorder | Tremor, GI effects, renal or thyroid injury, toxicity | NSAIDs, ACEI or ARB, thiazides, dehydration | Verify level, renal and thyroid status, sodium and fluid changes |
Drug class review
Sedation, anesthesia and paralysis
Procedures, ventilation, anesthesia
These drugs can abolish consciousness, breathing, airway reflexes, or movement. Paralysis does not provide sedation or analgesia.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Propofol | Procedural and ICU sedation | Apnea, hypotension, bradycardia, hypertriglyceridemia | Other CNS depressants | Continuous airway and hemodynamic monitoring |
| Dexmedetomidine | ICU and procedural sedation | Bradycardia, hypotension | Other rate-slowing drugs | Verify HR, BP, and sedation goal |
| Midazolam | Sedation, seizures | Respiratory depression, hypotension, paradoxical agitation | Opioids, CYP3A4 inhibitors | Continuous respiration and sedation monitoring |
| Ketamine | Anesthesia and analgesia | Emergence effects, hypertension, secretions | CNS depressants, sympathomimetics | Verify BP and airway readiness |
| Succinylcholine | Rapid paralysis | Hyperkalemia, malignant hyperthermia, bradycardia | Volatile anesthetics; risk conditions | No sedation or analgesia; verify contraindications and ventilation |
| Rocuronium, vecuronium | Paralysis | Prolonged weakness, anaphylaxis | Aminoglycosides and other blockers | Ensure sedation, analgesia, and mechanical ventilation |
Drug class review
Reproductive and obstetric drugs
Contraception, labor, hemorrhage, hypertensive emergencies
Pregnancy and lactation alter benefit and risk decisions. Verify gestational context, fetal assessment, contraindications, and unit protocols.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Ethinyl estradiol combinations | Contraception, cycle control | VTE, hypertension, nausea | Enzyme inducers; smoking increases vascular risk | Verify pregnancy, VTE, migraine, and smoking risks |
| Oxytocin | Induction or augmentation; postpartum hemorrhage | Tachysystole, fetal compromise, water intoxication, hypotension | Other uterotonics | Continuous maternal, fetal, and contraction monitoring per protocol |
| Magnesium sulfate | Preeclampsia seizure prevention; fetal neuroprotection | Flushing, weakness, respiratory depression, loss of reflexes | CNS depressants, calcium-channel blockers | Verify reflexes, respirations, urine output, and level per protocol |
| Methylergonovine | Postpartum hemorrhage | Hypertension, vasospasm | Other vasoconstrictors | Avoid or hold with hypertension per protocol |
| Carboprost | Postpartum hemorrhage | Diarrhea, fever, bronchospasm | Other uterotonics | Avoid or verify with asthma |
| Misoprostol | Cervical ripening, uterine atony, ulcer prevention | Fever, diarrhea, uterine tachysystole | Other uterotonics | Use route- and dose-specific obstetric protocol |
| Terbutaline | Selected uterine tachysystole; bronchodilation | Tachycardia, tremor, hyperglycemia | Other sympathomimetics | Verify maternal HR and BP and fetal response |
Drug class review
Electrolytes, renal drugs and blood products
Electrolyte correction, anemia, renal disease, transfusion
Electrolytes are medications. Route, concentration, infusion rate, renal function, ECG findings, compatibility, and repeat labs determine safety.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Potassium chloride | Hypokalemia | Hyperkalemia, dysrhythmia, vein injury | ACEI, ARB, potassium-sparing diuretics | Never IV push; verify potassium, renal function, rate, concentration |
| Magnesium sulfate | Hypomagnesemia, torsades, obstetric uses | Hypotension, weakness, respiratory depression | CNS depressants | Verify magnesium, reflexes and respirations in high-dose use, renal function |
| Calcium gluconate | Symptomatic hypocalcemia; membrane stabilization | Bradycardia, extravasation | Digoxin; product-specific compatibility | Verify line, rhythm, and compatibility |
| Sodium bicarbonate | Selected acidosis, hyperkalemia, toxicology uses | Alkalosis, sodium and fluid load, low ionized calcium | Many IV incompatibilities | Use indication-specific protocol and ABG or chemistry |
| Epoetin alfa | CKD or chemotherapy anemia | Hypertension, thrombosis | Iron status affects response | Verify hemoglobin target, BP, iron |
| RBCs, platelets, plasma | Anemia, bleeding, coagulation indications | Hemolytic, allergic, febrile reactions, TACO, TRALI | Compatibility and product requirements | Stop transfusion and follow reaction protocol for suspected reaction |
Drug class review
Immunology, allergy and vaccines
Allergy, immune disease, prevention
Epinephrine is first-line for anaphylaxis. Immunosuppressants and biologics increase infection risk. Vaccines require product-specific schedules and screening.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Diphenhydramine | Allergy, dystonia adjunct | Sedation, anticholinergic effects | Alcohol and CNS depressants | Fall and airway risk; not a substitute for epinephrine in anaphylaxis |
| Cetirizine, loratadine | Allergic rhinitis, urticaria | Drowsiness, dry mouth | CNS depressants | Verify renal or hepatic dosing when relevant |
| Epinephrine IM | Anaphylaxis | Tachycardia, tremor, hypertension | Beta blockers may blunt response | Do not delay in anaphylaxis; monitor and repeat per protocol |
| Tacrolimus, cyclosporine | Transplant and immune suppression | Nephrotoxicity, hypertension, infection, neurotoxicity | Many CYP3A4 drugs; grapefruit | Verify trough, renal function, BP, interactions |
| Methotrexate | Autoimmune disease; cancer | Marrow, liver, lung toxicity; fetal harm | TMP-SMX, NSAIDs, alcohol | Verify CBC, liver, renal, pregnancy; distinguish weekly from daily dosing |
| Common vaccines | Infection prevention | Local reaction, fever; rare anaphylaxis | Immunosuppression affects live vaccines | Screen contraindications, route, interval, and product |
Drug class review
Antineoplastic essentials
Cancer therapy
Cancer drugs are regimen-specific and hazardous. Verify diagnosis, protocol, cycle and day, body-size basis, labs, organ function, line, premedications, and independent checks.
| Drugs | What they treat | Common + serious effects | Key interactions | Verify / hold / escalate |
|---|---|---|---|---|
| Cyclophosphamide | Hematologic and solid tumors | Myelosuppression, hemorrhagic cystitis, infertility | Other marrow suppressants | Verify CBC, hydration or mesna plan, urine |
| Doxorubicin | Hematologic and solid tumors | Cardiomyopathy, myelosuppression, vesicant injury | Other cardiotoxic drugs | Verify lifetime dose, cardiac function, blood return |
| Cisplatin | Solid tumors | Nephrotoxicity, ototoxicity, severe nausea, electrolyte loss | Other nephrotoxic or ototoxic drugs | Verify hydration, renal function, magnesium, potassium, hearing |
| Paclitaxel | Breast, ovarian, lung cancers | Neuropathy, myelosuppression, hypersensitivity | CYP modifiers | Premedicate per protocol; monitor infusion reaction |
| Methotrexate | Leukemia, lymphoma, solid tumors | Mucositis, marrow, liver, renal toxicity | NSAIDs, TMP-SMX, PPIs in high-dose context | Verify level, leucovorin, and hydration protocol |
| Checkpoint inhibitors | Multiple cancers | Immune-mediated organ inflammation | Immunosuppressive treatment affects response | Report new diarrhea, cough, rash, endocrine, or neurologic symptoms |
High-yield safety
Medication safety patterns worth memorizing
Class knowledge helps predict what to assess before and after administration.
Bleeding
Anticoagulants, antiplatelets, thrombolytics, NSAIDs, and chemotherapy.
Respiratory depression
Opioids, benzodiazepines, sedatives, anesthesia drugs, and high-risk combinations.
QT or dysrhythmia
Antiarrhythmics, some antibiotics, antipsychotics, antidepressants, and antiemetics; risk rises with low potassium or magnesium.
Renal injury
NSAIDs, aminoglycosides, vancomycin, and vulnerable ACEI or ARB plus diuretic combinations.
Serotonin toxicity
Multiple serotonergic drugs; watch agitation, clonus, hyperreflexia, and fever.
Hypoglycemia
Insulin and sulfonylureas; beta blockers can mask adrenergic warning signs.
Severe skin reaction
Mucosal lesions or systemic symptoms with a new rash are urgent.
Marrow suppression
Connect CBC trends to infection and bleeding risk.
Reference notes
Sources + clinical boundaries
Drug labeling and standards change; verify current information before clinical use.